Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RESTORE Declined Livers Study

NCT: NCT04483102 · COMPLETED

NCT IDNCT04483102
StatusCOMPLETED
Start Date2020-12-03
Completion2025-05-14
SponsorWashington University School of Medicine (OTHER)
First posted
Last updated

Brief Summary

This is a prospective, non-randomized, clinical trial of discarded liver transplants that have received normothermic machine perfusion (NMP), compared with standard cold preservation liver transplants. The discarded livers rejected by all other centers and meeting pre-NMP eligibility criteria will receive NMP using the OrganOx® metra device. The NMP-treated liver that meets the viability criteria will be transplanted to patients who are eligible and consented to the study. Liver transplant outcomes will be ascertained during 12 months post-transplantation. The results of the trial will be compared with those of contemporary comparison groups of patients who received the standard criteria donor liver transplantation.

Frequently Asked Questions

What is RESTORE Declined Livers Study?

RESTORE Declined Livers Study is a clinical trial registered under NCT04483102. Current status: COMPLETED.

What is the status of NCT04483102?

The current status of NCT04483102 (RESTORE Declined Livers Study) is: COMPLETED.

When did RESTORE Declined Livers Study start?

RESTORE Declined Livers Study started on 2020-12-03.

Related Devices

PMA P200035Normothermic machine perfusion system for the preservation of donor livers prior to transplantationOrganox Limited PMA P160013Normothermic machine perfusion system for the preservation of standard criteria donor lungs prior to transplantationTransMedics, Inc. PMA P200031Normothermic machine perfusion system for the preservation of donor livers prior to transplantationTransMedics, Inc. PMA P180014Normothermic preservation system for transplantation of initially unacceptable donor lungsXvivo Perfusion, Inc. PMA P240033Normothermic preservation system for transplantation of initially unacceptable donor lungsLung Bioengineering, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑